Sangrix Inc. (SGRX)
NASDAQ: SGRX · Real-Time Price · USD
1.560
-0.030 (-1.89%)
At close: Sep 24, 2026, 4:00 PM EDT
1.590
+0.030 (1.92%)
Pre-market: Sep 25, 2026, 4:32 AM EDT

Sangrix Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
-0.042.896.260.19
Revenue Growth
--98.63%-53.87%3155.03%-
Cost of Revenue
--3.8310.830.4
Gross Profit
-0.04-0.95-4.57-0.21
Selling, General & Admin
2.753.083.822.914.23
Other Operating Expenses
--0.010.180.05
Operating Expenses
3.363.035.036.445.9
Operating Income
-3.36-2.99-5.97-11-6.11
Interest Expense
-1.13-0.46-0.5-0.23-0.05
Interest & Investment Income
0.21----
Other Non Operating Income (Expenses)
-10.92-0.92-2.950.32-0
EBT Excluding Unusual Items
-15.2-4.37-9.42-10.91-6.17
Gain (Loss) on Sale of Investments
---2.39-0.61-
Asset Writedown
---6.47-16.69-
Other Unusual Items
-8.74-2.15--0.82
Pretax Income
-23.93-6.52-18.28-28.22-5.34
Earnings From Continuing Operations
-23.93-6.52-18.28-28.22-5.34
Earnings From Discontinued Operations
----8.58
Net Income to Company
-23.93-6.52-18.28-28.223.24
Minority Interest in Earnings
0.01-0.020.75--
Net Income
-23.93-6.53-17.53-28.223.24
Net Income to Common
-23.93-6.53-17.53-28.223.24
Net Income Growth
-----
Shares Outstanding (Basic)
0000-
Shares Outstanding (Diluted)
0000-
Shares Change
341.08%340.80%59.85%--
EPS (Basic)
-70.43-84.84-1003.41-2581.55-
EPS (Diluted)
-70.43-84.84-1003.41-2581.55-
EPS Growth
-----

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-2.92-2.29-7.93-6.88-22.54
Free Cash Flow Per Share
-8.61-29.74-453.82-629.15-
Gross Margin
-100.00%-32.72%-72.92%-109.71%
Operating Margin
--7574.86%-206.82%-175.73%-3175.82%
Profit Margin
--16543.83%-606.95%-450.66%1684.10%
Free Cash Flow Margin
--5799.74%-274.51%-109.83%-11717.24%
EBITDA
--2.09-5.07-5.64-5.83
EBITDA Margin
---175.63%-90.09%-
D&A For EBITDA
-0.90.95.360.28
EBIT
-3.36-2.99-5.97-11-6.11
EBIT Margin
---206.82%-175.73%-
Revenue as Reported
-0.042.896.260.19
SEC Filings: 10-K · 10-Q